Life-Threatening Wunderlich Syndrome Associated with Apixaban and the Complexity of Anticoagulation Management in Bleeding Patients: A Case Report

• DOI: 10.20344/amp.16941
• Publication Date: 2022-07-08T14:40:20Z
• Authors: Sérgio Maltês; Cristina Carvalho...; Filipa Serrazina; Marta Rebelo
• Keywords: Apixaban

Wunderlich syndrome is a rare and possibly life-threatening haemorrhagic presenting as spontaneous nontraumatic renal rupture with subcapsular perinephric haemorrhage. Apixaban, direct oral anticoagulant recommended in patients atrial fibrillation, has previously been associated atraumatic solid organ but, to date, no case of apixaban-related reported. We report apixaban while addressing the difficulties face by clinicians when managing anticoagulation bleeding patients.